CDSCO Flags 167 Drug Samples as Substandard, Seven Found Spurious
India’s drug regulator has identified 167 medicine samples that failed quality tests and classified seven additional samples as spurious during routine surveillance conducted in December. The findings were released as part of the Central Drugs Standard Control Organisation’s (CDSCO) monthly drug alert.
Central Drugs Standard Control Organisation | 22/01/2026 | By Darshana | 116
CDSCO Flags 205 Not of Standard Quality Drug Samples in November Despite Data Gaps from States
Even as data submissions were pending from nearly 18 states and five Union Territories, the Central Drugs Standard Control Organisation (CDSCO) reported a total of 205 drug samples as Not of Standard Quality (NSQ) during November 2025.
Central Drugs Standard Control Organisation | 26/12/2025 | By Darshana | 192
CDSCO Mandates Online Submission of CGTP Clinical Trial Applications via SUGAM Portal
For now on, offline submissions of clinical trial applications for Cell and Gene Therapy Products (CGTPs) will not be accepted by the CDSCO.
Central Drugs Standard Control Organisation | 11/07/2025 | By Dineshwori | 289
NRA Meets WHO International Standards for Vaccine Regulations
WHO has established global standards and benchmarks for assurance of vaccine quality through the development of tools and guidelines, benchmarking of the NRA and prequalification programme of vaccines.
Central Drugs Standard Control Organisation | 14/10/2024 | By Aishwarya | 674
ENTOD Pharma Gets CDSCO Approval for PresVu to Treat Age-Related Vision Impairment
ENTOD Pharmaceuticals has gained approval from the Central Drugs Standard Control Organisation (CDSCO) for PresVu to treat age-related vision impairment.
Central Drugs Standard Control Organisation | 19/04/2024 | By Aishwarya | 903
CDSCO Issues Guidelines to Curb Circulation of Substandard Pharmaceuticals
Central Drugs Standard Control Organisation (CDSCO) has recently issued draft guidelines on good distribution practices to curb the introduction of spurious, adulterated and sub-standard pharmaceutical products in the market.
Central Drugs Standard Control Organisation | 19/04/2024 | By Aishwarya | 1082
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy